University of Manitoba, Winnipeg, Manitoba, Canada.
University of Manitoba, Winnipeg, Manitoba, Canada.
Can J Cardiol. 2014 Feb;30(2):173-80. doi: 10.1016/j.cjca.2013.11.022. Epub 2013 Nov 23.
Functional mitral regurgitation (FMR) is a challenging clinical entity that frequently complicates ischemic and nonischemic cardiomyopathy. The underlying pathophysiology of FMR is caused primarily by ventricular and subvalvular apparatus dysfunction which causes failure of proper leaflet coaptation. Echocardiography is the primary modality used in diagnosis and characterization of FMR. Echocardiography allows for assessment of valvular and ventricular structures and their interaction. FMR portends a poor prognosis, because it is frequently associated with increased morbidity and mortality. The optimal management of FMR involves an individualized approach that incorporates medical therapy and consideration of surgical, percutaneous, and resynchronization therapies according to the severity of regurgitation, presence of symptoms, option for revascularization, and the degree of ventricular remodelling.
功能性二尖瓣反流(FMR)是一种具有挑战性的临床病症,常并发于缺血性和非缺血性心肌病。FMR 的潜在病理生理学主要由心室和瓣下装置功能障碍引起,导致瓣叶对合不良。超声心动图是诊断和评估 FMR 的主要手段。超声心动图可以评估瓣膜和心室结构及其相互作用。FMR 预示着预后不良,因为它常与更高的发病率和死亡率相关。FMR 的最佳治疗方法涉及个体化治疗,根据反流严重程度、症状存在与否、血运重建选择和心室重构程度,综合考虑药物治疗和手术、经皮、心脏再同步化等治疗方法。